Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.20.1
Condensed Balance Sheets - USD ($)
Dec. 31, 2019
Mar. 31, 2019
Current assets:    
Cash & cash equivalents $ 99,447
Accounts receivable 24,788
Prepaid & other current assets 38,197 66,878
Total current assets 38,197 191,113
Property and equipment, net 101,443 102,378
Intangible assets, net 245,051 275,407
Deferred offering costs 181,051 104,141
TOTAL ASSETS 565,742 673,039
Current liabilities:    
Accounts payable 1,246,771 517,807
Accrued expenses 562,997 95,040
Accrued interest 379,795 130,101
Cash overdraft 1,720
Notes payable, net of debt discount of $154,182 2,992,028 1,926,117
Warrant liability 1,462,624 1,398,617
Related party payable, net 48,741
Total current liabilities 6,694,676 4,067,682
Total liabilities 6,694,676 4,067,682
Commitments and Contingencies (Note 12)
STOCKHOLDERS' DEFICIT:    
Preferred stock, par value $0.0001; 50,000,000 shares authorized, no shares outstanding
Common stock, par value $0.0001; 200,000,000 shares authorized; 16,716,000 shares outstanding as of December 31, 2019 and 9,875,000 shares outstanding as of March 31, 2019 1,672 988
Additional paid-in capital 8,015,567 3,448,857
Accumulated deficit (14,146,173) (6,844,488)
Total stockholders' deficit (6,128,934) (3,394,643)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 565,742 $ 673,039